Instalab
logoInstalab

Max Stenosis Circumflex

See exactly how narrowed one of your heart's main arteries has become, before it triggers a heart attack.
4.9 (4,032 reviews)
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Max Stenosis Circumflex test?

This test is most useful if any of these apply to you.

Worried About Your Heart
You want to know whether real plaque is building in your arteries, not just whether your cholesterol numbers look good on paper.
Family History of Early Heart Disease
A parent or sibling had a heart attack young, and you want to see your own coronary anatomy before symptoms force the conversation.
Heading Into AF Ablation
Silent narrowing here roughly doubles the odds your atrial fibrillation returns after ablation, and you want to know first.
Tracking Whether Treatment Is Working
You have known coronary disease and want to see whether statins, diet, and lifestyle are actually changing the artery, not just lab numbers.

About Max Stenosis Circumflex

Your heart muscle relies on three main arteries to stay fed. The left circumflex (LCx) is one of them, wrapping around the back of your heart and supplying blood to a large portion of the left ventricle. When this artery narrows, the muscle it feeds gets less oxygen, and the risk of angina, heart attack, and dangerous rhythm problems climbs.

Max Stenosis Circumflex is an imaging-derived number that captures the worst point of narrowing along this artery, expressed as a percentage. It is read from a CT coronary angiogram or an invasive angiogram, and it lets you and your cardiologist see exactly where you sit on the spectrum from clean artery to severely blocked vessel.

What This Number Actually Measures

This is not a blood test and not a molecule. It is a measurement of the tightest spot in your left circumflex artery, scored as the percentage of the vessel's normal opening that is blocked by plaque. A reading of 0% means a clean vessel. A reading of 70% means only 30% of the original opening is still available for blood to flow through at the worst spot.

The number is usually reported as part of a broader coronary imaging report alongside the same measurement for the left main, the left anterior descending (LAD), and the right coronary artery (RCA). Each vessel gets its own max stenosis value because narrowing in one artery tells you almost nothing about the others.

Why the Circumflex Specifically Matters

The circumflex is often the artery that surprises people. It tends to accumulate plaque differently from the LAD or the RCA, and analysis of more than 1,300 patients found that plaque progression is more frequent and more severe in the circumflex than in the right coronary or the LAD. That means a clean LAD does not guarantee a clean circumflex, and the circumflex can be the vessel quietly building disease while attention is elsewhere.

Its location also makes it vulnerable in specific situations. The circumflex runs close to the mitral valve and the coronary sinus, and procedures in that area, including mitral valve repair and certain ablations for atrial fibrillation, can compress or injure the vessel. In one study of mitral isthmus ablation, 28% of patients had acute narrowing or occlusion of the circumflex or its branches during the procedure, most of it without symptoms.

Heart Attack and Ischemia Risk

A severely narrowed circumflex restricts blood flow to a large portion of the heart muscle. The clinical thresholds used in research and reporting systems are familiar across all coronary arteries: a stenosis of 50% or more is considered obstructive, and 70% or more is considered severe. These are the cutoffs that machine-learning models trained on coronary CT use to flag patients for further workup.

What this means for you: if the worst point in your circumflex crosses 50%, that artery is no longer a bystander in your cardiovascular risk picture. It is doing measurable damage to blood flow under stress, even if you feel fine at rest.

Atrial Fibrillation Recurrence

Circumflex narrowing has a less obvious but well-documented link to atrial fibrillation. In a study of 496 patients with persistent AF and no known coronary disease, those with asymptomatic circumflex obstruction of 50% or more on CT were about twice as likely to have their AF return after catheter ablation. The hazard ratio was around 2.3, and this was independent of other risk factors.

What this means for you: if you are heading into an AF ablation, knowing whether your circumflex is silently narrowed changes the realistic odds that the procedure will hold. It is information you want before, not after, you are wheeled in.

Procedures Are Harder When the Narrowing Is at the Ostium

Location within the circumflex matters. When the narrowing sits right at the opening of the vessel where it branches from the left main, treatment outcomes get worse. A propensity-matched analysis of 287 patients found that stenting at the ostium of the circumflex led to a target lesion revascularization rate of 15%, compared with 2% for the same procedure at the ostium of the LAD. That is a hazard ratio of 7.5 for needing the lesion treated again.

What this means for you: knowing not just the percentage of narrowing but where in the artery it sits changes the calculus around how, when, and whether to treat it.

How the Number Is Read and Why It Varies

The way the image is acquired changes the number on the report. In patients with heavy calcium deposits in their arteries, standard CT scanners overestimate how narrow the vessel actually is. When the same lesions are scanned with ultra-high-resolution photon-counting CT, the measured stenosis drops by about 11% on average. Some lesions get downgraded from moderate to mild or minimal.

This applies across all the main coronary arteries, including the circumflex. A reading of 70% on a standard scanner with heavy calcification could be closer to 59% on a higher-resolution scanner. The number is real, but it lives inside a measurement system with known limits.

Research-Based Risk Tiers

These thresholds come from CT and invasive angiography research and are widely used across coronary vessels, including the circumflex. They are not specific to a single guideline body, and your reporting lab may use slightly different language. Use them as orientation, not as fixed targets.

TierMax StenosisWhat It Suggests
MinimalLess than 25%Plaque is present but blood flow is not meaningfully restricted at this spot.
Mild25% to 49%Visible narrowing, generally not flow-limiting, but a signal that disease is building.
Moderate (obstructive)50% to 69%Crosses the threshold where ischemia becomes plausible under stress.
Severe70% or moreSignificant obstruction. Often associated with symptoms and a candidate for further functional or invasive workup.

Because measurement varies by scanner type and by reader, compare results within the same imaging center and modality over time. A 5% shift on a repeat scan at a different facility may reflect the equipment, not your biology.

Tracking Your Trend

A single coronary CT is a snapshot of where your disease is today. The more useful question is which direction your circumflex is moving over years. Plaque progression in the circumflex tends to be both more frequent and more severe than in the other two main arteries, which is exactly why serial tracking matters for this specific vessel.

For most people with mild to moderate findings, a reasonable cadence is a baseline scan now, repeat imaging in 2 to 3 years if you are actively modifying your risk factors, and follow-up sooner if symptoms change. People with severe findings or rapid progression should be working with a cardiologist who can guide a more aggressive schedule.

What to Do If Your Number Is Elevated

An elevated max stenosis in the circumflex is rarely an isolated finding. The decision pathway depends on the full picture: what your LAD and RCA look like, whether you have symptoms, whether the narrowing sits at the ostium or further downstream, and whether you have other markers of plaque vulnerability.

  • Mild narrowing (under 50%): Treat as confirmation that your prevention plan needs to be tighter. This is not a surgical question. It is a lipid, blood pressure, glucose, and lifestyle question.
  • Moderate narrowing (50 to 69%): Bring this to a cardiologist. A functional test such as stress imaging or fractional flow reserve helps decide whether this lesion is actually limiting blood flow.
  • Severe narrowing (70% or more): Cardiology referral is non-negotiable. Treatment options range from intensive medical therapy to angioplasty with stenting, depending on symptoms, location, and the rest of your coronary anatomy.
  • Ostial narrowing of the circumflex specifically: Procedural outcomes are harder at this location. If a stent is being discussed, ask about operator experience and alternative strategies.

When Results Can Be Misleading

Three factors most often distort what your circumflex reading actually means.

  • Heavy calcification: Calcium blooms on standard CT images, making the lumen look narrower than it really is. Ultra-high-resolution photon-counting CT reduces this artifact by about 11 percentage points on average. If your scan was done on a standard scanner and the report flags significant calcium, the true narrowing may be less than the number suggests.
  • Scanner and reader differences: Two radiologists can read the same scan slightly differently, and two scanners can produce slightly different numbers from the same anatomy. Track your trend at the same facility when possible.
  • Recent cardiac procedures: Ablation procedures near the mitral valve, mitral valve repair, and other interventions in that region can cause acute narrowing of the circumflex that may not reflect long-standing atherosclerotic disease. Timing of imaging relative to any recent procedure matters.

What Moves This Biomarker

Evidence-backed interventions that affect your Max Stenosis Circumflex level

Decrease
High-intensity statin therapy
High-intensity statins are the most effective single class of drug for shrinking the plaque that drives circumflex narrowing. A meta-analysis of lipid-lowering trials found high-intensity statins produced the largest reductions in total atheroma volume and the largest increases in fibrous cap thickness (which stabilizes plaque) compared with other lipid-lowering strategies. Effects on stenosis percentage are slower than on plaque volume.
MedicationModerate Evidence
Decrease
PCSK9 inhibitors added to statin therapy
Adding a PCSK9 inhibitor (a newer injectable cholesterol-lowering drug) to high-intensity statin therapy produces additional plaque regression beyond statins alone. The GLAGOV trial of 968 patients showed evolocumab added to statins significantly reduced plaque progression at 18 months. The PACMAN-AMI trial of 300 patients after a heart attack showed alirocumab plus high-intensity statin significantly improved plaque regression in non-infarct arteries (including the circumflex territory) at 52 weeks.
MedicationModerate Evidence
Decrease
Icosapent ethyl (prescription EPA) on top of statins
In patients with elevated triglycerides already on statins, icosapent ethyl (a purified form of the omega-3 EPA) significantly reduced low-attenuation plaque, the most dangerous type of plaque, over 18 months. This was the primary finding of the EVAPORATE trial of 80 patients. Effects on the worst point of narrowing in the circumflex specifically were not reported separately.
SupplementModerate Evidence
Decrease
Intensive lifestyle modification (diet, exercise, stress management, no smoking)
Intensive, structured lifestyle programs have produced measurable regression of coronary plaque in randomized trials. The Lifestyle Heart Trial showed that a low-fat plant-based diet, smoking cessation, stress management, and moderate exercise led to regression of atherosclerosis over one year, with continued benefit at five years. A more recent trial of 92 patients with nonobstructive disease found that controlled diet and lifestyle on top of medical therapy reduced noncalcified plaque volume compared with medical therapy alone.
LifestyleModerate Evidence
Decrease
Regular aerobic exercise combined with a low-fat diet
In a randomized trial of 113 patients with stable angina, regular physical exercise combined with a low-fat diet slowed the progression of coronary artery disease over one year compared with usual care. The treated group showed less narrowing progression and more regression on follow-up angiography.
ExerciseModerate Evidence
Decrease
Ezetimibe added to statin therapy
Adding ezetimibe to a statin produces additional plaque regression beyond statin alone. A meta-analysis found ezetimibe-statin combination significantly reduced total atheroma volume compared with statin monotherapy, though it did not show improvement in fibrous cap thickness or lumenal stenosis in the analyzed window. The effect on the worst point of narrowing in any single artery, including the circumflex, is modest in the short term.
MedicationModest Evidence

Frequently Asked Questions

References

16 studies
  1. Koons EK, Rajiah P, Thorne J, Weber NM, Kasten H, Shanblatt E, Mccollough C, Leng SJournal of Cardiovascular Computed Tomography2023
  2. Mccollough C, Rajiah P, Bois JP, Winfree T, Carter RE, Rajendran K, Williamson EE, Thorne J, Leng SRadiology2023
  3. Gupta V, Pétursson P, Rawshani a, Borén J, Råmunddal T, Bhatt DL, Omerovic E, Angerås OOpen Heart2025
  4. Garcia R, Clouard M, Plank F, Degand B, Philibert S, Laurent G, Guenancia CFrontiers in Cardiovascular Medicine2022
  5. Espejo-paeres C, Vedia O, Wang L, Hennessey B, Mejía-rentería H, Mcinerney a, Jiménez-quevedo PHeart2023